BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

398 related articles for article (PubMed ID: 24423467)

  • 1. A cross-sectional study of surveillance of adverse drug reactions in inpatient departments of a tertiary care hospital.
    Remesh A; Balan A; Gnanadurai A
    J Basic Clin Physiol Pharmacol; 2014 Feb; 25(1):125-30. PubMed ID: 24423467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequency, types, severity, preventability and costs of Adverse Drug Reactions at a tertiary care hospital.
    Geer MI; Koul PA; Tanki SA; Shah MY
    J Pharmacol Toxicol Methods; 2016; 81():323-34. PubMed ID: 27109493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adverse Drug Reactions in Hospitalized Pediatric Patients: A Prospective Observational Study.
    Kurian J; Mathew J; Sowjanya K; Chaitanya KR; Ramesh M; Sebastian J; Narayanappa D
    Indian J Pediatr; 2016 May; 83(5):414-9. PubMed ID: 26916890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adverse drug reaction monitoring in a secondary care hospital in South India.
    Arulmani R; Rajendran SD; Suresh B
    Br J Clin Pharmacol; 2008 Feb; 65(2):210-6. PubMed ID: 17662089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pattern of adverse drug reactions notified by spontaneous reporting in an Indian tertiary care teaching hospital.
    Jose J; Rao PG
    Pharmacol Res; 2006 Sep; 54(3):226-33. PubMed ID: 16781163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adverse drug reaction monitoring: support for pharmacovigilance at a tertiary care hospital in Northern Brazil.
    Lobo MG; Pinheiro SM; Castro JG; Momenté VG; Pranchevicius MC
    BMC Pharmacol Toxicol; 2013 Jan; 14():5. PubMed ID: 23298396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An analysis of adverse drug reactions to radiographic contrast media reported during a 3 year period in a tertiary care hospital in south India.
    Subathra A; Sandhiya S; Kesavan R
    Indian J Physiol Pharmacol; 2014; 58(1):45-50. PubMed ID: 25464676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adverse drug reactions in a psychiatric department of tertiary care teaching hospital in India: Analysis of spontaneously reported cases.
    Patel TK; Bhabhor PH; Desai N; Shah S; Patel PB; Vatsala E; Panigrahi S
    Asian J Psychiatr; 2015 Oct; 17():42-9. PubMed ID: 26216702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adverse drug reactions in a south Indian hospital--their severity and cost involved.
    Ramesh M; Pandit J; Parthasarathi G
    Pharmacoepidemiol Drug Saf; 2003 Dec; 12(8):687-92. PubMed ID: 14762985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adverse drug reactions in patients in an Iranian department of internal medicine.
    Pourseyed S; Fattahi F; Pourpak Z; Gholami K; Shariatpanahi SS; Moin A; Kazemnejad A; Moin M
    Pharmacoepidemiol Drug Saf; 2009 Feb; 18(2):104-10. PubMed ID: 19101919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pediatric pharmacovigilance in an institute of national importance: Journey has just begun.
    Sharma PK; Misra AK; Gupta N; Khera D; Gupta A; Khera P
    Indian J Pharmacol; 2017; 49(5):390-395. PubMed ID: 29515280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug safety reports on complementary and alternative medicines (ayurvedic and homeopathic medicines) by a spontaneous reporting program in a tertiary care hospital.
    Jose J; Rao PG; Kamath MS; Jimmy B
    J Altern Complement Med; 2009 Jul; 15(7):793-7. PubMed ID: 19534607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study of pattern & distribution of adverse drug reactions in acute coronary syndrome patients in a tertiary care hospital.
    Mahadevappa M; Meher C; Pushpa NB; Kulkarni P; Poornima KS; Desai N
    Indian J Med Res; 2022 Jul; 156(1):111-121. PubMed ID: 36510903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Under-reporting of adverse drug reactions: a challenge for pharmacovigilance in India.
    Tandon VR; Mahajan V; Khajuria V; Gillani Z
    Indian J Pharmacol; 2015; 47(1):65-71. PubMed ID: 25821314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adverse drug reactions at adverse drug reaction monitoring center in Raipur: Analysis of spontaneous reports during 1 year.
    Singh P; Agrawal M; Hishikar R; Joshi U; Maheshwari B; Halwai A
    Indian J Pharmacol; 2017; 49(6):432-437. PubMed ID: 29674797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of adverse drug reactions with commonly prescribed drugs in different hospitals of Kathmandu valley.
    Jha N; Bajracharya O; Namgyal T
    Kathmandu Univ Med J (KUMJ); 2007; 5(4):504-10. PubMed ID: 18604084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inter-rater agreement between WHO- Uppsala Monitoring Centre system and Naranjo algorithm for causality assessment of adverse drug reactions.
    More SA; Atal S; Mishra PS
    J Pharmacol Toxicol Methods; 2024; 127():107514. PubMed ID: 38768933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adverse drug reactions: trends in a tertiary care hospital.
    Rehan HS; Chopra D; Sah RK; Mishra R
    Curr Drug Saf; 2012 Nov; 7(5):384-8. PubMed ID: 23150923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A retrospective analysis of reporting of adverse drug reactions to oncology drugs: An experience from a national center of clinical excellence.
    Sharma PK; Misra AK; Gupta A; Singh S; Dhamija P; Pareek P
    Indian J Pharmacol; 2018; 50(5):273-278. PubMed ID: 30636831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adverse Drug Reaction Profile of Anticancer Agents in a Tertiary Care Hospital: An Observational Study.
    Shaikh SP; Nerurkar R
    Curr Drug Saf; 2022; 17(2):136-142. PubMed ID: 34433404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.